When a women’s epithelium is thin and dry, much like a wilted rose, there is no estrogen leading to the problem known as Vulvovaginal Atrophy (VVA). Tissues of a woman’s vagina no longer work in their normal, healthy way.
The number of women suffering with Vulvovaginal Atrophy (VVA) is staggering. That’s why Durga is on a mission to revolutionize women’s sexual wellbeing.
64 Million
Women Experiencing VVA in the US
300+ Million
Women Experiencing VVA Globally
Active Ingredient
• On Market for 20+ years
• Most widely prescribed drugs
• Available as generic prescription
US MARKET
64M x 12 months of treatment = 767M annual scripts
Current treatment = $4320 annually
Average usage length = 30 years
Global Market
300M x 12 months of treatment = 3.6B annual scripts
Current treatment = $4320annually
Average usage length = 30 years
The Durga Prescription Drug is patent pending in the US and international market.
Canadian patent awarded in January 2023.
Take the first step, and contact us. Send us a message, and we will get back to you soon.
RN MS WHNP FNP-BC, President & CEO
35 years as a nurse practitioner
Earned Undergraduate and Graduate degrees from Ohio State University
Board President Alumni Society, Ohio State University College of Nursing
Durga inventor
Durga patent owner
Copyright © 2024 DURGA ENTERPRISES LLC - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.